Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection

Transplantation

Volumn 72, Issue 12, 2001, Pages 1898-1906

  Niemann, Heiner ^a   Verhoeyen, Els ^b   Wonigeit, Kurt ^c   Lorenz, Ralf ^c   Hecker, Jens ^c   Schwinzer, Reinhard ^c   Hauser, Hansjörg ^b   Kues, Wilfried A ^a   Halter, Roman ^d   Lemme, Erika ^a   Herrmann, Doris ^a   Winkler, Michael ^c   Wirth, Dagmar ^b   Paul, Dieter ^e  

^a INSTITUT FÜR TIERZUCHT   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c D 30625 Medizinische Hochschule

^d FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^e Institut für Tierzucht und Tierverhalten ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; FETUS; FIBROBLAST; GRAFT REJECTION; IMMUNITY; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SWINE; TRANSGENE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION;

EID: 0035668542     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200112270-00006     Document Type: Article

References (47)

1. Xenogeneic transplantation
2. Xenotransplantation. Problems and prospects
3. The generation of transgenic pigs as potential organ donors for humans
4. Morphology of hDAF (CD55) transgenic pig kidneys following ex vivo hemoperfusion with human blood
5. Alteration of complement activity: A strategy for xenotransplantation
6. Characterization of pigs transgenic for human decay-accelerating factor
7. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates
8. Progress in xenotransplantation
9. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection
10. Life-supporting pig to primate renal xeno-transplantion using genetically modified donors
11. Status of research with transgenic farm animals
12. Transgenic livestock: Premises and promises
13. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion
14. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection
15. Association of the 5'HS4 sequence of the chicken β-globin locus control region with human EF1α gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits
16. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
17. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice
18. A multifunctional vector family for gene expression in mammalian cells
19. Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection
20. Complement protected amphotropic retroviruses from murine packaging cells
21. Cell cycle synchronization of porcine fetal fibroblasts: Effects of serum deprivation and reversible cell cycle inhibitors
22. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
23. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model
24. Physiological and histological characterisation of a pig kidney in vitro perfusion model for xenotransplantation studies
25. Influence of cold ischemia time, pretransplant anti-porcine antibodies and donor/recipient size matching on hyperacute graft rejection following discordant porcine to cynomologus kidney transplantation
26. Organs from animals for man
27. Recent advances in xenotransplantation
28. Modification of vascular responses in xenotransplantation: Inflammation and apoptosis
29. Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination
30. Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord
31. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
32. Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats
33. The enhancer domain of human cytomegalovirus major immediate-early promoter determines cell typespecific expression in transgenic mice
34. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFKB
35. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
36. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium
37. Functional expression of human CD59 in transgenic mice
38. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF
39. Introns increase transcriptional efficiency in transgenic mice
40. Heterologous introns can enhance expression of transgenes in mice
41. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep
42. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor
43. Pig cloning by microinjection of fetal fibroblast nuclei
44. Cloned pigs produced by nuclear transfer from adult somatic cells
45. Production of cloned pigs from in vitro systems
46. Production of genetargeted sheep by nuclear transfer from cultured somatic cells
47. Elimination of potential sites of glycosylation fails to abrogate complement regulatory function of cell surface CD59